AstraZeneca PLC Ordinary Shares (AZN)

Cost of Revenue

$2.52B

Quarterly · Period ending: · USD

AZN logo

AZN Cost of Revenue

Latest reported$2.52B
AZN Quarterly Cost of Revenue ($0.00 → $2.52B)
High-resolution chart · PNG

AZN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,523,000,000
2,678,000,000
3,118,000,000
2,801,000,000
2,473,000,000
2,241,000,000
2,725,000,000
3,081,000,000
2,183,000,000
2,218,000,000
2,308,000,000
2,095,000,000
1,960,000,000
1,905,000,000
2,900,000,000
2,982,000,000
2,998,000,000
3,511,000,000
4,625,000,000
3,757,000,000
2,191,000,000
1,864,000,000
1,525,000,000
1,370,000,000
984,000,000
1,420,000,000
1,378,000,000
1,351,000,000
1,063,000,000
1,129,000,000
1,637,000,000
1,153,000,000
1,012,000,000
1,134,000,000
1,225,000,000
1,249,000,000
950,000,000
894,000,000
1,160,000,000
900,000,000
1,062,000,000
1,004,000,000
1,269,000,000
1,041,000,000
1,067,000,000
1,269,000,000
1,667,000,000
1,415,000,000
1,307,000,000
1,453,000,000
1,440,000,000
1,238,000,000
1,317,000,000
1,266,000,000
1,398,000,000
1,274,000,000
1,346,000,000
1,375,000,000
1,612,000,000
1,593,000,000
1,482,000,000
1,339,000,000
1,759,000,000
1,524,000,000
1,452,000,000
1,654,000,000
1,665,000,000
1,263,000,000
1,464,000,000
1,383,000,000
2,112,000,000
1,585,000,000
1,431,000,000
1,470,000,000
2,141,000,000
1,405,000,000
1,469,000,000
1,404,000,000
1,578,000,000
1,339,000,000
1,391,000,000
1,305,000,000
1,388,000,000
1,245,000,000
1,313,000,000
1,410,000,000
1,455,000,000
1,286,000,000
1,251,000,000
1,158,000,000
1,057,000,000
1,168,766,463
1,106,363,098
1,136,870,438
1,047,647,005
1,160,246,528
1,060,000,000
1,094,000,000
0
1,064,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.